Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Calvarial Langerhans cell histiocytosis in an Adult: Typical imaging findings in an atypical age group.

Samara A, Nepute J, Lu HC, Perrin RJ, Eldaya RW.

Radiol Case Rep. 2019 Oct 9;14(12):1478-1482. doi: 10.1016/j.radcr.2019.09.009. eCollection 2019 Dec.

2.

The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.

Li Z, Farias FHG, Dube U, Del-Aguila JL, Mihindukulasuriya KA, Fernandez MV, Ibanez L, Budde JP, Wang F, Lake AM, Deming Y, Perez J, Yang C, Bahena JA, Qin W, Bradley JL, Davenport R, Bergmann K, Morris JC, Perrin RJ, Benitez BA, Dougherty JD, Harari O, Cruchaga C.

Acta Neuropathol. 2019 Aug 27. doi: 10.1007/s00401-019-02066-0. [Epub ahead of print]

PMID:
31456032
3.

Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.

Xu J, Sun J, Perrin RJ, Mach RH, Bales KR, Morris JC, Benzinger TLS, Holtzman DM.

Ann Clin Transl Neurol. 2019 Aug;6(8):1423-1434. doi: 10.1002/acn3.50837. Epub 2019 Jul 9.

4.

A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.

Del-Aguila JL, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Fernandez MV, Ibanez L, Bradley J, Wang F, Bergmann K, Davenport R, Morris JC, Holtzman DM, Perrin RJ, Benitez BA, Dougherty J, Cruchaga C, Harari O.

Alzheimers Res Ther. 2019 Aug 9;11(1):71. doi: 10.1186/s13195-019-0524-x.

5.

Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study.

Han F, Perrin RJ, Wang Q, Wang Y, Perlmutter JS, Morris JC, Benzinger TLS, Xu J.

Parkinsons Dis. 2019 Jul 4;2019:7975407. doi: 10.1155/2019/7975407. eCollection 2019.

6.

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.

Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Farias FHG, Fernández MV, Ibanez L, Jiang S, Perrin RJ, Cairns NJ, Morris JC, Harari O, Cruchaga C.

Mol Neurodegener. 2019 May 8;14(1):18. doi: 10.1186/s13024-019-0319-3.

7.

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma.

Johanns TM, Miller CA, Liu CJ, Perrin RJ, Bender D, Kobayashi DK, Campian JL, Chicoine MR, Dacey RG, Huang J, Fritsch EF, Gillanders WE, Artyomov MN, Mardis ER, Schreiber RD, Dunn GP.

Oncoimmunology. 2019 Jan 25;8(4):e1561106. doi: 10.1080/2162402X.2018.1561106. eCollection 2019.

8.

Structural signature of sporadic Creutzfeldt-Jakob disease.

Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM.

Eur J Neurol. 2019 Aug;26(8):1037-1043. doi: 10.1111/ene.13930. Epub 2019 Mar 25.

PMID:
30735286
9.

Author response: In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Day GS, Gordon BA, Perrin RJ, Ances BM.

Neurology. 2019 Jan 15;92(3):150. doi: 10.1212/WNL.0000000000006771. No abstract available.

PMID:
30643031
10.

Acquired mania associated with a left temporal meningioma.

Shen SQ, Sinha N, Perrin RJ, Ghoshal N, Hawasli AH, Womer FY.

Bipolar Disord. 2018 Dec;20(8):774-777. doi: 10.1111/bdi.12711. Epub 2018 Nov 16. No abstract available.

PMID:
30447044
11.

Widespread distribution of tauopathy in preclinical Alzheimer's disease.

Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, Morris JC, Ances BM, Benzinger TLS.

Neurobiol Aging. 2018 Dec;72:177-185. doi: 10.1016/j.neurobiolaging.2018.08.022. Epub 2018 Sep 1.

12.

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.

Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT.

Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.

13.

In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, Morris JC, Benzinger TLS, Ances BM.

Neurology. 2018 Mar 6;90(10):e896-e906. doi: 10.1212/WNL.0000000000005064. Epub 2018 Feb 7.

14.

Polymer Coating Embolism: Cause of Cerebral Vasculopathy and Death following Congenital Heart Repair in Two Infants.

Mehta RI, Perrin RJ, Baldzizhar R, Mehta RI.

J Neuropathol Exp Neurol. 2017 Nov 1;76(11):978-980. doi: 10.1093/jnen/nlx079. No abstract available.

15.

A 71-Year-Old Man Presenting with Headache, Blurry Vision and Alexia without Agraphia.

Cimino PJ, Perrin RJ.

Brain Pathol. 2016 Nov;26(6):799-800. doi: 10.1111/bpa.12448. No abstract available.

PMID:
27647576
16.

Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.

Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, Soares HD, Kling MA, Mailman M, Arnold SE, Narayan VA, Lee VM, Shaw LM, Baker D, Wittenberg GM, Trojanowski JQ, Wang LS.

Alzheimers Dement (Amst). 2015 Sep 1;1(3):339-348.

17.

Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes.

Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Simpson JR, Robinson CG, Chicoine MR, Perrin RJ, Huang J, Kim AH.

Neurosurgery. 2016 Jul;79(1):23-32. doi: 10.1227/NEU.0000000000001160.

PMID:
26645969
18.

Dural arteriovenous fistula-induced thalamic dementia: report of 4 cases.

Holekamp TF, Mollman ME, Murphy RK, Kolar GR, Kramer NM, Derdeyn CP, Moran CJ, Perrin RJ, Rich KM, Lanzino G, Zipfel GJ.

J Neurosurg. 2016 Jun;124(6):1752-65. doi: 10.3171/2015.5.JNS15473. Epub 2015 Nov 20.

PMID:
26587655
19.

Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.

Franklin EE, Perrin RJ, Vincent B, Baxter M, Morris JC, Cairns NJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):815-22. doi: 10.1016/j.jalz.2015.05.010. Review.

20.

Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN).

Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network.

Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.

21.

Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection.

Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR, Kim AH.

Neurosurgery. 2014 Oct;75(4):356-63; discussion 363. doi: 10.1227/NEU.0000000000000462. Erratum in: Neurosurgery. 2014 Dec;75(6):733.

PMID:
24932708
22.

Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.

Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR.

Neurosurgery. 2014 Oct;75(4):347-54; discussion 354-5; quiz 355. doi: 10.1227/NEU.0000000000000461.

PMID:
24932707
23.

Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma.

Cimino PJ Jr, Perrin RJ.

Appl Immunohistochem Mol Morphol. 2014 Jul;22(6):442-8. doi: 10.1097/PAI.0b013e318294ca46.

24.

Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.

Perrin RJ, Payton JE, Malone JP, Gilmore P, Davis AE, Xiong C, Fagan AM, Townsend RR, Holtzman DM.

PLoS One. 2013 May 20;8(5):e64314. doi: 10.1371/journal.pone.0064314. Print 2013.

25.

Tumefactive demyelination in a patient with human immunodeficiency virus.

Solomon IH, Perrin RJ, Clifford DB, Ances BM.

J Neurovirol. 2013 Jun;19(3):265-9. doi: 10.1007/s13365-013-0165-y. Epub 2013 May 4. No abstract available.

26.

Recurrent adult-onset hypophyseal Langerhans cell histiocytosis after radiotherapy: a case report.

Funk RK, Ferraro DJ, Perrin RJ, Hurth KM, Stephens JJ, Mansur DB, Chicoine MR, Simpson JR, Jaboin JJ.

J Med Case Rep. 2012 Oct 8;6:341. doi: 10.1186/1752-1947-6-341.

27.

Cerebrospinal fluid biomarkers for clinical trials: why markers for differential diagnosis are important.

Perrin RJ.

Arch Neurol. 2012 Nov;69(11):1407-8. No abstract available.

PMID:
22926002
28.

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Fagan AM, Perrin RJ.

Biomark Med. 2012 Aug;6(4):455-76. doi: 10.2217/bmm.12.42. Review.

29.

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis.

Craig-Schapiro R, Kuhn M, Xiong C, Pickering EH, Liu J, Misko TP, Perrin RJ, Bales KR, Soares H, Fagan AM, Holtzman DM.

PLoS One. 2011 Apr 19;6(4):e18850. doi: 10.1371/journal.pone.0018850.

30.

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM.

PLoS One. 2011 Jan 12;6(1):e16032. doi: 10.1371/journal.pone.0016032.

31.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM.

Biol Psychiatry. 2010 Nov 15;68(10):903-12. doi: 10.1016/j.biopsych.2010.08.025. Erratum in: Biol Psychiatry. 2011 Feb 15;69(4):389.

32.

TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.

Cairns NJ, Perrin RJ, Schmidt RE, Gru A, Green KG, Carter D, Taylor-Reinwald L, Morris JC, Gitcho MA, Baloh RH.

Neuropathol Appl Neurobiol. 2010 Dec;36(7):673-9. doi: 10.1111/j.1365-2990.2010.01121.x. No abstract available.

33.

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease.

Perrin RJ, Fagan AM, Holtzman DM.

Nature. 2009 Oct 15;461(7266):916-22. doi: 10.1038/nature08538. Review.

34.

Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Ghoshal N, Cali I, Perrin RJ, Josephson SA, Sun N, Gambetti P, Morris JC.

Arch Neurol. 2009 Oct;66(10):1240-6. doi: 10.1001/archneurol.2009.224.

35.

Pathology quiz case 2. Atypical meningioma with clear cell features (World Health Organization [WHO] grade II).

Brenner MJ, Perrin RJ, Uppaluri R, Zipfel GJ, Lewis JS Jr.

Arch Otolaryngol Head Neck Surg. 2008 Apr;134(4):447-9. doi: 10.1001/archotol.134.4.447. No abstract available.

PMID:
18427017
36.

Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Wippold FJ 2nd, Lubner M, Perrin RJ, Lämmle M, Perry A.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1633-8. Epub 2007 Sep 24. Review.

37.

Iatrogenic intradural epidermoid cyst after lumbar puncture. Case illustration.

Refai D, Perrin RJ, Smyth MD.

J Neurosurg. 2007 Apr;106(4 Suppl):322. No abstract available.

PMID:
17465371
38.

Structural determinants of PLD2 inhibition by alpha-synuclein.

Payton JE, Perrin RJ, Woods WS, George JM.

J Mol Biol. 2004 Apr 2;337(4):1001-9.

PMID:
15033366
39.

Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines.

Perrin RJ, Payton JE, Barnett DH, Wraight CL, Woods WS, Ye L, George JM.

Neurosci Lett. 2003 Oct 2;349(2):133-5.

PMID:
12946570
40.

Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.

Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ.

J Neurosci. 2003 Apr 1;23(7):2564-71.

41.

Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells.

Payton JE, Perrin RJ, Clayton DF, George JM.

Brain Res Mol Brain Res. 2001 Nov 1;95(1-2):138-45.

PMID:
11687285
42.

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins.

Perrin RJ, Woods WS, Clayton DF, George JM.

J Biol Chem. 2001 Nov 9;276(45):41958-62. Epub 2001 Sep 11.

43.
44.

Angiographically cryptic histologically verified cerebrovascular malformations.

Cohen HC, Tucker WS, Humphreys RP, Perrin RJ.

Neurosurgery. 1982 Jun;10(6 Pt 1):704-14. No abstract available.

PMID:
7110544

Supplemental Content

Loading ...
Support Center